A battle over verifying online Canadian pharmacies goes to court

first_img [email protected] Pharmalot Jay Directo/AFP/Getty Images Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. A battle over verifying online Canadian pharmacies goes to court About the Author Reprints Ed Silverman STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Log In | Learn More center_img By Ed Silverman Aug. 14, 2019 Reprints What is it? As more Americans look to Canada for cheaper medicines, a company whose website is devoted to verifying prescription drugs sold by online pharmacies is suing five organizations, including two with ties to the pharmaceutical industry, for allegedly running a campaign to manipulate and suppress information available to consumers.In its lawsuit, PharmacyChecker.com claims the groups, including the National Association of Boards of Pharmacy, have essentially created a type of shadow regulation through private agreements with “key internet gatekeepers,” such as Google, to “choke off” information about importing medicines from online pharmacies in Canada and other countries. GET STARTED Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED @Pharmalot Tags drug pricinglegalpharmaceuticalsSTAT+ What’s included?last_img read more